$ASBP News

Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K

ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization

Aspire Biopharma shares are trading higher after the company announced a $5 million share buyback program.

Aspire Biopharma shares are trading higher after the company announced a $5 million share buyback program.

Aspire Biopharma Announces $5.0 Million Share Repurchase Program

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo

Aspire Biopharma shares are trading lower after the company announced it will acquire Dura Driver Control Systems for $30 million in cash.

Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

Aspire Biopharma Enters Into LOI To Acquire Dura Driver Control Systems For $30M In Cash

Aspire Biopharma shares are trading lower. The company announced a non-binding LOI to acquire 100% of driver controls systems business unit of Firefish Topco in a deal valued at $30 million.

Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion

Aspire Biopharma Enters Into Non-Binding LOI To Acquire 100% Of Driver Controls Systems Business Unit Of Firefish Topco From FTLLC Shareholders; Deal Valued At $30M; Aspire Does Not Anticipate New Equity Raise For Purchase

Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

Aspire Biopharma's Buzz Bomb Caffeine And TruLife Distribution Conclude Agreement; TruLife To Manage And Coordinate Sales, Distribution And Merchandising Of BUZZ BOMB To Retailers Nationwide

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack

Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief

Aspire Partners With Microsize To Create Quick-Dissolve Anxiety Drug